Scaffold hybridization in generation of indenoindolones as anticancer agents that induce apoptosis with cell cycle arrest at G2/M phase

Bioorganic & Medicinal Chemistry Letters
2012.0

Abstract

Scaffold hybridization of several natural and synthetic anticancer leads led to the consideration of indenoindolones as potential novel anticancer agents. A series of these compounds were prepared by a diversity-feasible synthetic method. They were found to possess anticancer activities with higher potency compared to etoposide and 5-fluorouracil in kidney cancer cells (HEK 293) and low toxicity to corresponding normal cells (Vero). They exerted apoptotic effect with blocking of cell cycle at G2/M phase.

Knowledge Graph

Similar Paper

Scaffold hybridization in generation of indenoindolones as anticancer agents that induce apoptosis with cell cycle arrest at G2/M phase
Bioorganic & Medicinal Chemistry Letters 2012.0
Indenoindolone derivatives as topoisomerase II–inhibiting anticancer agents
Bioorganic & Medicinal Chemistry Letters 2013.0
Multisubstituted indole–acrylonitrile hybrids as potential cytotoxic agents
Bioorganic & Medicinal Chemistry Letters 2014.0
Synthesis of novel indole-thiazolidinone hybrid structures as promising scaffold with anticancer potential
Bioorganic & Medicinal Chemistry 2021.0
Novel indolo-sophoridinic scaffold as Topo I inhibitors: Design, synthesis and biological evaluation as anticancer agents
European Journal of Medicinal Chemistry 2018.0
Synthesis and anticancer activity of 4β-alkylamidochalcone and 4β-cinnamido linked podophyllotoxins as apoptotic inducing agents
European Journal of Medicinal Chemistry 2012.0
Biological evaluation of indolizine-chalcone hybrids as new anticancer agents
European Journal of Medicinal Chemistry 2018.0
Unconventional Knoevenagel-type indoles: Synthesis and cell-based studies for the identification of pro-apoptotic agents
European Journal of Medicinal Chemistry 2015.0
Novel Antitumor Indolizino[6,7-b]indoles with Multiple Modes of Action: DNA Cross-Linking and Topoisomerase I and II Inhibition
Journal of Medicinal Chemistry 2013.0
Indole in the target-based design of anticancer agents: A versatile scaffold with diverse mechanisms
European Journal of Medicinal Chemistry 2018.0